MM Biobrændsel A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Bankruptcy risk for industry  1.1% 1.1% 1.1% 1.1% 1.1%  
Bankruptcy risk  1.7% 7.0% 2.8% 4.2% 4.2%  
Credit score (0-100)  75 36 59 47 48  
Credit rating  A BBB BBB BBB BBB  
Credit limit (kDKK)  2.5 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Net sales  933 191 1,413 1,628 1,260  
Gross profit  161 -35.6 230 110 128  
EBITDA  43.2 -210 104 -52.3 14.7  
EBIT  43.2 -210 104 -52.3 14.7  
Pre-tax profit (PTP)  39.5 -205.6 99.0 -52.1 16.3  
Net earnings  39.5 -230.5 77.2 -40.9 12.7  
Pre-tax profit without non-rec. items  39.5 -206 99.0 -52.1 16.3  

 
See the entire income statement

Balance sheet (kDKK) 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Tangible assets total  763 702 641 580 518  
Shareholders equity total  1,603 1,372 1,449 1,409 1,421  
Interest-bearing liabilities  348 0.0 212 2.0 0.9  
Balance sheet total (assets)  2,423 1,424 1,994 1,484 1,490  

Net Debt  -592 -402 147 -133 -21.9  
 
See the entire balance sheet

Volume 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Net sales  933 191 1,413 1,628 1,260  
Net sales growth  0.0% -79.5% 638.2% 15.2% -22.6%  
Gross profit  161 -35.6 230 110 128  
Gross profit growth  -2.5% 0.0% 0.0% -52.1% 16.3%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,423 1,424 1,994 1,484 1,490  
Balance sheet change%  22.7% -41.2% 40.0% -25.6% 0.4%  
Added value  43.2 -210.1 103.8 -52.3 14.7  
Added value %  4.6% -109.7% 7.3% -3.2% 1.2%  
Investments  -122 -61 -61 -61 -61  

Net sales trend  0.0 -1.0 1.0 2.0 -1.0  
EBIT trend  3.0 -1.0 1.0 -1.0 1.0  

Profitability 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
EBITDA %  4.6% -109.7% 7.3% -3.2% 1.2%  
EBIT %  4.6% -109.7% 7.3% -3.2% 1.2%  
EBIT to gross profit (%)  26.9% 590.7% 45.2% -47.6% 11.5%  
Net Earnings %  4.2% -120.4% 5.5% -2.5% 1.0%  
Profit before depreciation and extraordinary items %  4.2% -120.4% 5.5% -2.5% 1.0%  
Pre tax profit less extraordinaries %  4.2% -107.4% 7.0% -3.2% 1.3%  
ROA %  2.2% -10.5% 6.2% -2.9% 1.1%  
ROI %  2.5% -12.1% 6.8% -3.2% 1.2%  
ROE %  2.5% -15.5% 5.5% -2.9% 0.9%  

Solidity 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Equity ratio %  66.2% 96.4% 72.7% 94.9% 95.4%  
Relative indebtedness %  87.9% 12.2% 35.0% 2.2% 2.1%  
Relative net indebtedness %  -12.8% -198.0% 30.3% -6.1% 0.3%  
Net int. bear. debt to EBITDA, %  -1,371.0% 191.5% 141.2% 254.1% -149.0%  
Gearing %  21.7% 0.0% 14.7% 0.1% 0.1%  
Net interest  0 0 0 0 0  
Financing costs %  2.6% 1.9% 6.7% 1.1% 57.5%  

Liquidity 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Quick Ratio  2.0 30.9 2.4 25.1 36.9  
Current Ratio  2.0 30.9 2.7 25.1 36.9  
Cash and cash equivalent  939.7 402.4 65.9 134.8 22.7  

Capital use efficiency 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Trade debtors turnover (days)  12.1 593.3 186.9 167.1 275.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  177.9% 377.0% 95.7% 55.5% 77.1%  
Net working capital  839.3 698.5 858.8 868.0 945.5  
Net working capital %  90.0% 364.8% 60.8% 53.3% 75.1%  

Employee efficiency 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0